ARTLVSGLMD• 3 Months (Normalized)
ARTL vs GLMD (Artelo Biosciences Inc. vs Galmed Pharmaceuticals Ltd.)
Showing Closing Date Range from Jul 3 to Oct 1, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
GLMD Performance $3.55
+537.34%
Galmed Pharmaceuticals Ltd.
Normalized Baseline0.00%
Alpha Spread Margin GLMD LEADS
-537.34 pts
GLMD outperforming by 537.34 percentage points
ARTLGLMD
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL GLMD
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | ARTL Price | ARTL Gain (%) | GLMD Price | GLMD Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $3.55 | +537.34% | - | |
| Sep 28, 2026 | $- | $3.63 | +551.71% | - | |
| Sep 25, 2026 | $4.54 | -53.72% | $3.63 | +551.71% | -605.43% |
| Sep 24, 2026 | $5.17 | -47.30% | $3.62 | +549.91% | -597.21% |
| Sep 23, 2026 | $7.31 | -25.48% | $3.62 | +549.91% | -575.39% |
| Sep 22, 2026 | $4.15 | -57.70% | $- | - | |
| Sep 21, 2026 | $4.10 | -58.21% | $3.50 | +528.37% | -586.58% |
| Sep 18, 2026 | $3.94 | -59.84% | $3.40 | +510.41% | -570.25% |
| Sep 17, 2026 | $3.97 | -59.53% | $3.48 | +524.78% | -584.31% |
| Sep 16, 2026 | $3.75 | -61.77% | $3.41 | +512.21% | -573.98% |
| Sep 15, 2026 | $5.34 | -45.57% | $3.63 | +550.81% | -596.38% |
| Sep 14, 2026 | $4.87 | -50.36% | $3.82 | +585.82% | -636.18% |
| Sep 11, 2026 | $5.43 | -44.65% | $3.84 | +589.41% | -634.06% |
| Sep 10, 2026 | $5.63 | -42.61% | $4.03 | +623.52% | -666.13% |
| Sep 09, 2026 | $5.98 | -39.04% | $4.63 | +731.24% | -770.28% |
Page 1 of 5